1 / 11

Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

Active (E2F). Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1). Strategies for signalling inhibition. Immune effector cell. Anti-ligand mAbs. Bispecific Abs. scFv/toxin conjugates. Ligand/toxin conjugate. Ligand- genistein conjugates. Anti-receptor mAbs.

Download Presentation

Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Active (E2F) Activation 0f S-phase genes(Cycle E, A, E2Fs, DHFR,TK,TS,POL,CDK1)

  2. Strategies for signalling inhibition Immuneeffector cell Anti-ligand mAbs BispecificAbs scFv/toxinconjugates Ligand/toxin conjugate Ligand- genisteinconjugates Anti-receptormAbs Inhibitors of other signalling molecules Nucleus IntracellularscFvs Tyrosine kinase inhibitors (TKIs) Antisense

  3. Mode of action of EGFR inhibitors EGF/TGFα R R Antibody Extracellular Membrane û û Intracellular EGFR-TKI EGFR-TKI K K û Cell survival (anti-apoptosis) Proliferation Signalling DNA Growth factors Angiogenesis Chemotherapy/ radiotherapy sensitivity Metastasis R, epidermal growth factor receptor

More Related